| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Schaffer Derace L is a Director at Altimmune, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 20 buys and 5 sells.
Estimated insider holdings value: $4.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2019 | LNTH Lantheus Holdings, Inc. | Director | Sell | 10,000 | $24.71 | $247,127.00 | -37.0% | |
| Jun 4, 2019 | LNTH Lantheus Holdings, Inc. | Director | Sell | 20,000 | $23.82 | $476,383.98 | -17.8% | |
| Apr 1, 2019 | LNTH Lantheus Holdings, Inc. | Director | Sell | 10,000 | $24.41 | $244,094.00 | -17.5% | |
| Dec 29, 2017 | ALT Altimmune, Inc. | Director | Buy | 97,410 | $1.92 | $187,450.36 | +9.3% | |
| Dec 27, 2017 | ALT Altimmune, Inc. | Director | Buy | 147,130 | $1.76 | $259,356.40 | +9.3% | |
| Dec 7, 2017 | ALT Altimmune, Inc. | Director | Buy | 23,745 | $1.78 | $42,303.53 | +3.6% | |
| Dec 5, 2017 | ALT Altimmune, Inc. | Director | Buy | 26,010 | $1.79 | $46,587.57 | +2.9% | |
| Nov 30, 2017 | ALT Altimmune, Inc. | Director | Buy | 33,315 | $1.91 | $63,638.65 | +4.1% | |
| Nov 27, 2017 | ALT Altimmune, Inc. | Director | Buy | 21,808 | $2.03 | $44,282.19 | +3.0% | |
| Nov 21, 2017 | ALT Altimmune, Inc. | Director | Buy | 18,331 | $2.08 | $38,214.73 | +2.7% |